Company intelligence / Profile preview
Endomimetics
Birmingham, Alabama, United Statesendomimetics.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Endomimetics’ lead hydrogel (AVF GEL for arteriovenous fistula maturation) is in IND-enabling testing; other applications of its Bionanomatrix technology—including brain aneurysm devices, cardiovascular stent coatings, and dental applications—are being studied in preclinical research[6][2][1]. The company has demonstrated enhanced healing, reduced restenosis, and anti-thrombotic effects in preclinical models but has not yet reported clinical trial results[6][1].
- Therapeutic areas
- NeurologyCardiovascularOther
- Modalities
- Hydrogel-based drug delivery therapyPeptidesNanoparticle
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
03
Partnerships
BISCO, Inc. (for dental product development)[3][6]University of Alabama at Birmingham (licensing, foundational R&D)[1][2]
Beyond the preview
Go deeper on Endomimetics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Endomimetics.